JAY PHARMA INC has a total of 15 patent applications. Its first patent ever was published in 2016. It filed its patents most often in Australia, Canada and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals are EURODRUG LAB B V, CO ENZYME TECHNOLOGY LTD and ZHENGZHOU SAIKE PHARMACEUTICAL TECH CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 2 | |
#2 | Canada | 2 | |
#3 | EPO (European Patent Office) | 2 | |
#4 | Israel | 2 | |
#5 | United States | 2 | |
#6 | WIPO (World Intellectual Property Organization) | 2 | |
#7 | Brazil | 1 | |
#8 | China | 1 | |
#9 | Republic of Korea | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Dalgleish Angus | 6 |
#2 | Hall Nadine | 6 |
#3 | Geralnik Adela Juknat | 5 |
#4 | Uppalapati Lakshmi Narasaiah | 5 |
#5 | Vogel Zvi | 5 |
#6 | Nathan Ilana | 5 |
#7 | Lui Wai | 4 |
#8 | Liu Wai | 3 |
#9 | Adela Juknat Geralnik | 1 |
#10 | Zvi Vogel | 1 |
Publication | Filing date | Title |
---|---|---|
WO2021028646A1 | Administration regimes of cannabinoids in combination with chemotherapeutics against cancer | |
AU2019249887A1 | Combination of a cannabinoid and a chemotheraopeutic agent for the treatment of breast cancer | |
BR112018008601A2 | compositions comprising cannabidiol and second therapeutic agents for the treatment of cancer |